- Home
- BTBT vs FHTX Comparison
BTBT vs FHTX Comparison
Compare BTBT & FHTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BTBT | FHTX |
|---|---|---|
| Founded | 2015 | 2015 |
| Country | United States | United States |
| Employees | N/A | 106 |
| Industry | Finance: Consumer Services | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 427.6M | 266.6M |
| IPO Year | 2017 | 2020 |
Fundamental Metrics
Financial Performance| Metric | BTBT | FHTX |
|---|---|---|
| Price | $1.59 | $4.45 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 8 |
| Target Price | $6.00 | ★ $11.50 |
| AVG Volume (30 Days) | ★ 32.7M | 351.9K |
| Earning Date | 05-15-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 25.32 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $113,560,320.00 | $30,909,000.00 |
| Revenue This Year | $38.96 | $8.89 |
| Revenue Next Year | $89.41 | $20.13 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 5.10 | ★ 36.75 |
| 52 Week Low | $1.18 | $3.27 |
| 52 Week High | $4.55 | $7.61 |
Technical Indicators
Market Signals| Indicator | BTBT | FHTX |
|---|---|---|
| Relative Strength Index (RSI) | 53.63 | 28.07 |
| Support Level | $1.54 | $4.37 |
| Resistance Level | $1.74 | $4.59 |
| Average True Range (ATR) | 0.13 | 0.40 |
| MACD | 0.02 | -0.26 |
| Stochastic Oscillator | 61.92 | 1.04 |
Price Performance
Historical ComparisonAbout BTBT Bit Digital Inc.
Bit Digital Inc is engaged in the Bitcoin mining business, Ethereum staking activities and specialized cloud-infrastructure services for artificial intelligence applications through its wholly owned subsidiaries. Its mining platform operates with the primary intent of accumulating bitcoin which may sell for fiat currency from time to time depending on market conditions. The Company has four reportable segments: digital asset mining, cloud services, colocation services, and ETH Staking. It generates majority of its revenue from digital asset mining.
About FHTX Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin regulatory system. Its proprietary platform is designed to provide an integrated, mechanistic understanding of interactions within the chromatin regulatory system, supporting the identification and validation of potential therapeutic targets. The company's flagship program is FHD-909.